Alaunos Therapeutics Inc. (TCRT)
NASDAQ · Healthcare
Alaunos Therapeutics Inc. Revenue 2011–2025
Alaunos Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Alaunos Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Alaunos Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 2000, a 60.00% decrease year-over-year.
- Alaunos Therapeutics Inc. annual revenue for 2025 was 5000, a 50.00% decrease from 2024.
- Alaunos Therapeutics Inc. annual revenue for 2024 was 10000, a 100.00% increase from 2023.
- Alaunos Therapeutics Inc. annual revenue for 2023 was 5000, a 99.83% decrease from 2022.
- Alaunos Therapeutics Inc. annual revenue for 2022 was 2.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Alaunos Therapeutics Inc. Market Cap — FAQ
Alaunos Therapeutics Inc. (TCRT) market cap over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRT's market cap history?
The chart and table above show Alaunos Therapeutics Inc.'s market cap by year and by quarter, including the growth rate.